DCDaniela Josefina Cataneo-Piña

Daniela Josefina Cataneo-Piña

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniela Josefina Cataneo-Piña has a total of 64 co-authors. Here are the top co-authors by number of shared publications:

  • Natalia Sánchez-Garrido

    National Institute of Geriatrics (N.S.-G.), Mexico City, Mexico

    3 shared publications
  • Adriana Bautista-Ruiz

    National Institute of Respiratory Diseases (INER) (D.J.C.-P., L.A.M.-P., B.P.C.-M., A.B.-R., B.P.S.-H., I.B.-R.), Mexico City, Mexico

    2 shared publications
  • Blanca Patricia Sánchez-Hernández

    National Institute of Respiratory Diseases (INER) (D.J.C.-P., L.A.M.-P., B.P.C.-M., A.B.-R., B.P.S.-H., I.B.-R.), Mexico City, Mexico

    2 shared publications
  • Brenda Paola Castillo-Marmolejo

    National Institute of Respiratory Diseases (INER) (D.J.C.-P., L.A.M.-P., B.P.C.-M., A.B.-R., B.P.S.-H., I.B.-R.), Mexico City, Mexico

    2 shared publications
  • Eduardo Ortiz-Reyes

    2 shared publications
  • Gloria Pérez-Rubio

    HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico

    2 shared publications

Latest Publications

  • Open Access

    Plasma Interleukin‐10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID‐19 Treated With Corticosteroids

    by Ingrid Fricke‐Galindo, Francisco M. Ortega‐Villafuerte, Gloria Pérez‐Rubio, Ivette Buendía‐Roldán, Julián Ramírez‐Bello, Azael A. Castillo Morales, Leslie Chávez‐Galán, Rafael de Jesús Hernández‐Zenteno, Espiridión Ramos‐Martínez, Salvador García‐Carmona, et al.

    We aimed to evaluate the association between IL10 variants and plasma IL‐10 levels and clinical outcomes in patients with severe COVID‐19 treated with corticosteroids. We studied 944 patients with severe COVID‐19 who were treated with corticosteroids. The clinical outcomes evaluated were in‐hospital mortality and the requirement of invasive mechanical ventilation (IMV). The variants IL10 rs1800872, rs1554286, rs3024505, and rs3122605 were determined using TaqMan SNP assays, and IL‐10 levels were measured by ELISA at the start of corticosteroid treatment (T1) and after 8 days (T2). The rs1800872‐TT ( p = 0.035, OR = 1.55, 95% CI = 1.03–2.33) and the rs1554286‐AA genotypes were associated with IMV ( p adj = 0.036, OR = 2.42, 95% CI = 1.12–5.95). IL‐10 levels were higher at T1 than at T2. At T2, IL‐10 levels were higher in non‐survivors (15.9 vs. 7.0 pg/mL, p < 0.001) and in patients requiring IMV (9.9 vs. 5.5 pg/mL, p < 0.001). Among non‐survivors, IL‐10 plasma levels did not decrease at T2. The alluvial plot revealed that 51.9% of patients in the highest IL‐10 tertile at T1 remained in the highest tertile at T2, with a mortality rate of 50%. IL10 rs1800872 and rs1554286 contribute to the risk of requiring IMV. Elevated IL‐10 levels after corticosteroid treatment were linked to in‐hospital mortality and IMV.

  • Geriatric Vulnerability and Symptom Burden as Determinants of Palliative Care in Respiratory Disease

    by Daniela Josefina Cataneo-Piña, Ana Patricia Navarrete-Reyes, Lidia Aurora Mondragón-Posadas, Brenda Paola Castillo-Marmolejo, Adriana Bautista-Ruiz, Blanca Patricia Sánchez-Hernández, Natalia Sánchez-Garrido, Ivette Buendía-Roldán

  • Open Access

    The respiratory geriatric severity index (RGSI): A multidimensional prognostic tool integrating geriatric syndromes to predict in-hospital mortality in older adults with respiratory diseases

    by Daniela Josefina Cataneo-Piña, Natalia Sánchez-Garrido, Blanca Patricia Sánchez-Hernández, Lidia Aurora Mondragón-Posadas, Brenda Paola Castillo-Marmolejo, Adriana Bautista-Ruiz, Miguel Ángel Mendoza-Escamilla, Eduardo Ortiz-Reyes, Elizabeth Pacheco-Marín, María Fernanda Santana-Balderas, et al.

  • Open Access

    OPG and TNFR1 as Potential Biomarkers of Inflammation in Older Adults with Acute COVID-19 and Indicators of Frailty in Post-COVID-19: A Pilot Study

    by Lucero Ramon-Luing, Julio Flores-Gonzalez, Daniela Josefina Cataneo-Piña, Ramcés Falfán-Valencia, Gloria Pérez-Rubio, Ivette Buendia-Roldan, Moisés Selman, Leslie Chavez-Galan

    Background: Older individuals are at high risk for severe COVID-19 and often experience geriatric syndromes as post-COVID-19 sequelae associated with inflammation. Osteoprotegerin (OPG) and Tumor Necrosis Factor Receptor 1 (TNFR1) are emerging as promising biomarkers in inflammation-associated diseases. Here, these and other members of the tumor necrosis factor superfamily (TNFSF) were investigated as potential biomarkers to monitor older adults during acute COVID-19 and post-COVID-19 recovery. Patients and Methods: This study included 75 patients with acute COVID-19, 26 post-COVID-19 (evaluated at 4 and 12 months), 35 healthy donors (HD), and 36 individuals with interstitial lung diseases (ILD), all aged over 60. Plasma levels of 14 soluble TNFSF members were measured using flow cytometry-based multiplex immunoassays and ELISA. Multiple logistic regression and ROC curve analyses were performed to assess the potential of TNFSF members as biomarkers. Results: Flow cytometry revealed significantly higher levels of OPG, BAFF, and APRIL in acute COVID-19 patients than in HD and ILD (p< 0.001). Through an ELISA, high levels of OPG (p< 0.0001), APRIL (p< 0.05), and BAFF (p< 0.0001) were confirmed, and TNFR1 (p< 0.0001) was also revealed. In this pilot study, OPG and TNFR1 had AUCs > 0.90 and were predictive of COVID-19, independent of comorbidities, while BAFF levels were modified by diabetes. Persistently elevated OPG and TNFR1 levels were also observed in post-COVID-19 patients at 4 and 12 months. Notably, OPG levels were higher in frail versus non-frail individuals at both time points (p< 0.05), while TNFR1 levels were higher only at 4 months (p< 0.05). Conclusion: This evidence indicates that OPG and TNFR1 are potential biomarkers of inflammation during acute COVID-19 and post-COVID-19 among older, mainly frail adults. These findings support their utility in managing post-COVID-19 geriatric frailty syndrome.


  • Inflammatory mediators and lung function in older COVID-19 survivors.

    by Daniela Cataneo, Leslie Chávez-Galán, Lidia Mondragón-Posadas, Natalia Sánchez-Garrido, Ivette Buendía- Roldán

    Background: Severe COVID-19 in older adults is associated with multisystemic inflammation, leading to poor outcomes. The long-term consequences and how subacute inflammation affects pulmonary function remain unclear. Aim: to analyze the relationship between inflammatory cytokines four months after discharge and lung function one year later in severe COVID-19 older survivors, and the influence of steroid use in their performance. Methods: Twenty patients, predominantly female, were recruited from a specialized Post-COVID Care Clinic. Blood samples were collected four months after discharge, and flow cytometry was performed to measure intracellular cytokines in CD4+ T-cells. Pulmonary function tests were conducted one-year post-discharge. A Pearson correlation was done to assess the relationship between cytokine levels and pulmonary function. Results: At the four-month assessment, it was observed that patients exhibiting CD4+ T cells expressing IFN-γ (rho −0.673, p=0.008), IL-10 (rho −0.705, p=0.007), and IL-4 (rho −0.716, p=0.013) displayed a negative correlation with DLCO levels at the one-year follow-up. Conclusions: There is a statistically significant correlation between intracellular cytokines and reduced pulmonary function, particularly DLCO, at the one-year mark. Detection of inflammatory mediators four months after discharge from critical illness can help anticipate long-term pulmonary impairment in older survivors. Fig 1. Inverse correlation between four-months intracellular cytokines and one-year pulmonary function test in older adults who survived COVID-19

  • Open Access

    Enhancing quality of life in severe post-COVID-19 survivors through multidisciplinary care

    by Daniela Josefina Cataneo-Piña, Armando Castorena-Maldonado, Dulce González-Islas, Susana Galicia-Amor, Arturo Orea-Tejeda, Viridiana Pelaez-Hernández, Alma Delia Gutiérrez-Álvarez, Jorge Rojas-Serrano, Eduardo Ortiz-Reyes, Aline Mendoza-Méndez, et al.

    Background: COVID-19 survivors who were hospitalised continue to experience long-term multisystemic sequelae and symptoms, impacting their health-related quality of life (HRQoL). The complexity of post-COVID-19 conditions underscores the importance of adopting a multidisciplinary, patient-centric approach to ensure ongoing care. This study aims to assess HRQoL and post-COVID symptoms in a cohort of severe COVID-19 survivors depending on their participation in a multidisciplinary programme.Methods: This prospective study was conducted in a post-COVID clinic staffed by a multidisciplinary team (physical rehabilitator, nutritionist, psychologist, including experts in pulmonary rehabilitation, nutrition, psychology and others). Subjects over 18 years old who were hospitalised due to severe COVID-19 during the acute phase and had attended the post-COVID clinic within the first 3 months following discharge were included. Subjects who were unable or unwilling to provide informed consent to participate in the protocol were excluded. Linear mixed-effect models were employed to examine changes in 12-Item Short-Form Health Survey (SF-12) component scores. The resolution of post-COVID symptom clusters was compared using the Cox model.Results: A total of 730 patients were included, with a mean±sdage of 55.78±15.43 years; 60.55% were male and 90.62% required mechanical ventilation during hospitalisation. Programme attendants demonstrated improved SF-12 physical and mental component scores at 3 and 12 months. A reduction in the prevalence of post-COVID symptoms was observed in both groups, with greater reductions in those attending the programme.Conclusion: Our study showed that patients enrolled on the multidisciplinary programme experienced improvements in fatigue, musculoskeletal, gastrointestinal, neuropsychiatric and respiratory symptoms, along with enhanced SF-12 mental and physical component scores.


  • Open Access

    Geriatric care‐related outcomes in patients 75 years and older admitted to a pulmonary disease center and predictors for hospital‐related complications

    by Daniela Josefina Cataneo‐Piña, Celia Gabriela Hernández‐Favela, Lidia Aurora Mondragón‐Posadas, Citlalic Torres Nuñez

    Objective: The primary aim of this study was to evaluate the influence of targeted interventions, administered through comprehensive geriatric assessments on the incidence of hospitalization‐related complications among older adults diagnosed with pulmonary diseases.Methods: A retrospective analysis of medical records encompassed individuals aged 75 years and older who were admitted to a lung center during the period spanning from March to June 2023. These admissions occurred in a context where standardized geriatric management protocols were systematically implemented. This study's scope extended to assessing the prevalence of hospital‐related complications, encompassing delirium and pressure ulcers. A rigorous multivariate logistic regression analysis was conducted to discern and characterize associated factors.Results: The integration of comprehensive geriatric assessment yielded a substantial reduction in in‐hospital complications among the cohort of 118 patients (mean age : 82.1 ± 5.6 years, 44.5% women). The incidence of delirium decreased from 53.3% to 21.8% [odds ratio (OR): 0.246, 95% confidence interval (CI): 0.134–0.450, p < 0.001], whereas the presence of pressure ulcers decreased from 43.9% to 25% (OR: 0.395, 95% CI: 0.217–0.715, p < 0.001). The multivariate analysis uncovered independent associations between delirium and variables including community‐acquired pneumonia (OR: 4.417, 95% CI : 1.574–12.395, p = 0.005), severe disability (OR: 2.981, 95% CI: 1.140–7.798, p = 0.026), and hearing loss (OR: 3.219, 95% CI : 1.260–8.170, p = 0.014). Prolonged hospital stays emerged as the sole factor significantly associated with pressure ulcers (OR: 1.071, 95% CI: 1.033–1.109). Furthermore, an intricate bidirectional relationship was evident between delirium and pressure ulcers (OR: 7.158, 95% CI: 2.962–17.300, p < 0.01).Conclusion: In conjunction with its consequent interventions, geriatric evaluation assumes a pivotal role in ameliorating adverse outcomes stemming from hospitalization among older adults afflicted with pulmonary ailments. This role gains particular salience among subpopulations characterized by heightened susceptibility, such as individuals coping with hearing loss and severe disability.


  • Association of Th1/Th2 phenotype with changes in the frailty status among COVID-19 older survivors

    by Daniela Cataneo, Leslie Chavez-Galan, Ranferi Ocaña-Guzman, Armando Castorena-Maldonado, Ivette Buendía-Roldán

    Background: Aging is associated with persistent chronic inflammation and impairment in T cell responses, predisposing severe disease and mortality due to COVID-19 in the acute phase, and a more significant long-term burden of chronic diseases and frailty. Aims: To identify the association between T cell function and improving or worsening the frailty status at 4 and 12 months of follow-up by assessing cell proliferation and cytokine production. Methods: A cohort study of 60+ years old individuals (n=15) recruited four months after discharging due to severe COVID-19 and re-assessed at 12 months. Frailty was assessed through Fried´s phenotype criteria, and T cell subtypes were analyzed using flow cytometry. Two-way ANOVA was performed to detect the association between changes in the frailty status between both assessments and the activation phenotype of T helper cells. Results: Older adults who worsened their frailty status had a lower proportion of naïve T cells on the first assessment (fig. 1) and more outstanding production of proinflammatory cytokines such as INF-G at one year of follow-up (fig. 2). Patients who improved had lower TNF-a production at four months, less production of the suppressor cytokine IL-10, and a preserved Th1/Th2 proportion on the second assessment. Conclusions: COVID-19 older survivors who improve their frailty status at one year of follow-up have a preserved Th1/Th2 phenotype; nevertheless, those who worsen have more outstanding proinflammatory cytokine production.

  • Geriatric principles for patients with cancer

    by Ana Patricia Navarrete-Reyes, Karla Animas-Mijangos, Jimena Gómez-Camacho, Yoselin Juárez-Carrillo, Ana Cristina Torres-Pérez, Daniela Josefina Cataneo-Piña, Juan Pablo Negrete-Najar, Enrique Soto-Perez-De-Celis

    Cancer is primarily a disease of older persons. Given the heterogeneity of aging, physiological age, rather than chronological age, better expresses the cumulative effect of environmental, medical, and psychosocial stressors, which modifies life expectancy. Comprehensive geriatric assessment, a tool that helps ascertain the physiological age of older individuals, is the gold standard for assessing older adults with cancer. Several international organizations recommend using the geriatric assessment domains to identify unrecognized health problems that can interfere with treatment and predict adverse health-related outcomes, aiding complex treatment decision making. More recently, it has been shown that geriatric assessment-guided interventions improve quality of life and mitigate treatment toxicity without compromising survival. In this review, we discuss the role of comprehensive geriatric assessment in cancer care for older adults and provide the reader with useful information to assess potential treatment risks and benefits, anticipate complications, and plan interventions to better care for older people with cancer.